Disclaimer: This article was published in 2021 and reflects the information available at that time.
  The PDL Professional Officers have noted a recent reduction in the number of calls about the COVID-19 vaccination service. This is pleasing and a likely indication of reduced demands on pharmacists and a greater familiarity with the vaccination process. However, this phase of the pharmacy vaccination service brings other challenges. With the inclusion of the Pfizer Comirnaty vaccine into the pharmacy vaccination program, there are increased risks that need to be identified and managed by pharmacists and pharmacy owners. Managing three brands of vaccine Handling three different…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more
2024-2025 most reported medicines
8 October 2025
National
Learn more